LILLIE JAMES WOODRUFF (Chief Scientific Officer) received a stock award from MAPLIGHT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/19/2026ACC: 0001728746-26-000016
Officer· Chief Scientific Officer
Since Feb 2026
+39.13K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
39.13K acquired
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
+7.73K
Price / share
—
Trade value
—
% of position
3.8%
8/17/2026
202.38K→210.11K
Total
Net shares
+7.73K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 8/17/2026 | A · Award | +7.73K | — | — | 3.8% | 202.38K | 210.11K |
| Total | +7.73K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Voting Common Stock
31.39K shares
Shares
+31.39K
Strike price
11.245
Held after
31.39K
Exercisable
—
8/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Voting Common Stock31.39K shares | 8/17/2026 | A · Award | +31.39K | 11.245 | — | 31.39K |